| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/23/1995 | US5418129 Antitumor |
| 05/23/1995 | US5417970 Purity |
| 05/23/1995 | CA1335662C Peptide derivatives for the treatment and prevention of asthma and the like |
| 05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
| 05/23/1995 | CA1335654C Monoclonal antibodies capable of recognizing gangliosides go__ and gt |
| 05/23/1995 | CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1995 | WO1995013392A1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 05/18/1995 | WO1995013384A1 Tomato xyloglucan endo-transglycosylase |
| 05/18/1995 | WO1995013372A1 Brain-derived membrane-associated crf binding proteins |
| 05/18/1995 | WO1995013370A1 Haemophilus transferrin receptor genes |
| 05/18/1995 | WO1995013369A1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
| 05/18/1995 | WO1995013367A1 Neural axon outgrowth modulators |
| 05/18/1995 | WO1995013296A1 Receptor specific atrial natriuretic peptides |
| 05/18/1995 | WO1995013295A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 05/18/1995 | WO1995013293A1 Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME |
| 05/18/1995 | WO1995013292A1 Bcl-2-associated proteins |
| 05/18/1995 | WO1995013103A2 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 05/18/1995 | WO1995012982A1 Compositions and methods for producing and using homogeneous neuronal cell transplants |
| 05/18/1995 | CA2176378A1 Bcl-2-associated proteins |
| 05/18/1995 | CA2176217A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 05/18/1995 | CA2176216A1 Compositions and methods for producing and using homogeneous neuronal cell transplants |
| 05/18/1995 | CA2176133A1 Tomato xyloglucan endo-transglycosylase |
| 05/18/1995 | CA2175373A1 Brain-derived membrane-associated crf binding proteins |
| 05/18/1995 | CA2174966A1 Method for simultaneous identification of differentially expressed mrnas and measurement of relative concentrations |
| 05/18/1995 | CA2174735A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 05/17/1995 | EP0653489A1 Coccidiosis poultry vaccin |
| 05/17/1995 | EP0653440A1 Monoclonal antibodies against hair follicle, hybridomas producing them |
| 05/17/1995 | EP0653067A1 Method and kit for pyridinium crosslink assay |
| 05/17/1995 | EP0653064A1 Clinical test for detection of alzheimer's disease |
| 05/17/1995 | EP0652967A1 Self-assembling replication defective hybrid virus particles |
| 05/17/1995 | EP0652966A1 Method of increasing expression of viral proteins |
| 05/17/1995 | EP0652964A1 $i(K. LACTIS) TRANSALDOLASE GENE PROMOTER AND USE THEREOF |
| 05/17/1995 | EP0652960A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
| 05/17/1995 | EP0652959A1 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 05/17/1995 | EP0652956A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 05/17/1995 | EP0652954A1 A novel gene coding human epidermal growth factor and process for preparing the same |
| 05/17/1995 | EP0652953A1 Morphogenic protein soluble complex and composition thereof |
| 05/17/1995 | EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 05/17/1995 | EP0652951A1 Gdf-1 |
| 05/17/1995 | EP0652950A1 Generation of xenogeneic antibodies |
| 05/17/1995 | EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON |
| 05/17/1995 | EP0652901A1 Carboxy terminal il-6 muteins |
| 05/17/1995 | EP0652899A1 A fungicidally active compound |
| 05/17/1995 | EP0652897A1 Peptide inhibitors of selectin binding |
| 05/17/1995 | EP0652889A1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/17/1995 | EP0652758A1 Diphtheria toxin vaccines |
| 05/17/1995 | EP0274482B1 Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
| 05/16/1995 | US5416201 DNAs that code for mouse interleuken 4 |
| 05/16/1995 | US5416195 Polypeptide derivatives of granulocyte colony stimulating factor |
| 05/16/1995 | US5416021 Fibronectin binding protein-encoding DNA |
| 05/16/1995 | US5416007 Enhanced proteolytic cleavage of recombinant fusion proteins |
| 05/16/1995 | US5415995 Diagnostic peptides of human papilloma virus |
| 05/13/1995 | CA2135729A1 Monoclonal antibodies against hair follicle, hybridomas producing the antibodies, and a method for preparing the hybridomas |
| 05/13/1995 | CA2135547A1 Coccidiosis poultry vaccine |
| 05/11/1995 | WO1995012684A1 Methods for controlling sialic acid derivatives in recombinant glycoproteins |
| 05/11/1995 | WO1995012679A1 Anti-helminth vaccines |
| 05/11/1995 | WO1995012674A1 Human kunitz-type protease inhibitors |
| 05/11/1995 | WO1995012673A1 Receptor on the surface of activated t-cells: acts-4 |
| 05/11/1995 | WO1995012672A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/11/1995 | WO1995012670A1 Opioid receptor: compositions and methods |
| 05/11/1995 | WO1995012666A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 05/11/1995 | WO1995012663A1 Improved cell cultivation method and medium |
| 05/11/1995 | WO1995012617A1 Anti-human soluble fibrin antibody hybridoma, and immunoassaying method |
| 05/11/1995 | WO1995012614A1 Cd6 ligand |
| 05/11/1995 | WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | WO1995012412A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | WO1995008628A3 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 05/11/1995 | CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | CA2175247A1 Cd6 ligand |
| 05/11/1995 | CA2175214A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | CA2175209A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/11/1995 | CA2174533A1 Improved cell cultivation method and medium |
| 05/10/1995 | EP0652232A1 P53as protein and antibody therefor |
| 05/10/1995 | EP0652230A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/10/1995 | EP0651826A1 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 05/10/1995 | EP0651824A1 Transcription control element for increasing gene expression in myoblasts |
| 05/10/1995 | EP0651820A1 MONOCLONAL ANTIBODIES AGAINST THE $g(a)-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
| 05/10/1995 | EP0651819A1 Methods for human monoclonal antibody production |
| 05/10/1995 | EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 05/10/1995 | EP0651811A1 $i(K. LACTIS) RP28 RIBOSOMAL PROTEIN GENE PROMOTER AND USE THEREOF |
| 05/10/1995 | EP0651810A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 05/10/1995 | EP0651809A1 A family of map2 protein kinases |
| 05/10/1995 | EP0651806A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/10/1995 | EP0651805A1 Method of intracellular binding of target molecules |
| 05/10/1995 | EP0651804A1 Process for obtaining antibodies |
| 05/10/1995 | EP0651803A1 Protein expression system. |
| 05/10/1995 | EP0651802A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 05/10/1995 | EP0651800A1 Basophil granule proteins |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0651798A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 05/10/1995 | EP0651797A1 A method for generation of antibodies to cell surface molecules |
| 05/10/1995 | EP0651790A1 Type-c rotavirus cultures and uses therefor |
| 05/10/1995 | EP0651789A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 05/10/1995 | EP0651787A1 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor |
| 05/10/1995 | EP0651769A1 Leukaemia inhibitory factor-binding protein |
| 05/10/1995 | EP0651767A1 Biologically active polypeptides derived from an actinomycete |
| 05/10/1995 | EP0651766A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |